New guidelines proposed for life-sustaining treatment in Japan

New guidelines for life-sustaining treatment have been proposed in Japan, focusing on procedures for deciding whether to continue treatment after discussions with patients and families. The recommendations do not define the end of life.

According to The Japan Times, new guidelines for life-sustaining treatment have been proposed in Japan. The recommendations do not define the end of life but focus on procedures for deciding whether to continue treatment after discussions with patients and families. Published on March 18, 2026, the article highlights keywords such as health, hospitals, and medicine. These guidelines aim to clarify decision-making processes in medical settings.

Articles connexes

Deputies voting in the French Assembly on euthanasia legislation with vote results displayed.
Image générée par IA

Assembly adopts euthanasia bill for the third time

Rapporté par l'IA Image générée par IA

Deputies adopted the end-of-life bill on Tuesday by 295 votes to 232. The text legalizing euthanasia and assisted suicide now returns to the Senate before a final vote on July 15.

Japan has enacted a bill revising the adult guardianship system to permit individuals to opt out of support based on their specific needs.

Rapporté par l'IA

Mexico's Supreme Court will discuss a case on euthanasia and assisted suicide this week, brought by a woman with cancer seeking to repeal parts of the health law.

On Saturday, deputies completed their review of the end-of-life bill without including a clause allowing private institutions to refuse assisted dying. A protest drew four thousand people in Paris on Sunday.

Rapporté par l'IA

The Japanese legislature has advanced a proposal to allow the imperial family to adopt distant male relatives. Opposition lawmakers have criticized Sanae Takaichi over the imperial law revision.

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser